146 related articles for article (PubMed ID: 34185874)
1. Targeting sphingosine kinase-1 with the low MW inhibitor SKI-5C suppresses the development of endometriotic lesions in mice.
Rudzitis-Auth J; Christoffel A; Menger MD; Laschke MW
Br J Pharmacol; 2021 Oct; 178(20):4104-4118. PubMed ID: 34185874
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis.
Rudzitis-Auth J; Menger MD; Laschke MW
Hum Reprod; 2013 May; 28(5):1339-47. PubMed ID: 23427233
[TBL] [Abstract][Full Text] [Related]
3. Differences in growth and vascularization of ectopic menstrual and non-menstrual endometrial tissue in mouse models of endometriosis.
Nenicu A; Yordanova K; Gu Y; Menger MD; Laschke MW
Hum Reprod; 2021 Jul; 36(8):2202-2214. PubMed ID: 34109385
[TBL] [Abstract][Full Text] [Related]
4. Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions.
Nenicu A; Körbel C; Gu Y; Menger MD; Laschke MW
Hum Reprod; 2014 May; 29(5):1011-24. PubMed ID: 24578472
[TBL] [Abstract][Full Text] [Related]
5. Xanthohumol inhibits growth and vascularization of developing endometriotic lesions.
Rudzitis-Auth J; Körbel C; Scheuer C; Menger MD; Laschke MW
Hum Reprod; 2012 Jun; 27(6):1735-44. PubMed ID: 22447626
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of erythropoietin-producing hepatoma receptor B4 (EphB4) signalling suppresses the vascularisation and growth of endometriotic lesions.
Rudzitis-Auth J; Fuß SA; Becker V; Menger MD; Laschke MW
Br J Pharmacol; 2020 Jul; 177(14):3225-3239. PubMed ID: 32144768
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Hyaluronic Acid Synthesis Suppresses Angiogenesis in Developing Endometriotic Lesions.
Olivares CN; Alaniz LD; Menger MD; Barañao RI; Laschke MW; Meresman GF
PLoS One; 2016; 11(3):e0152302. PubMed ID: 27018976
[TBL] [Abstract][Full Text] [Related]
8. Notch signaling controls sprouting angiogenesis of endometriotic lesions.
Körbel C; Gerstner MD; Menger MD; Laschke MW
Angiogenesis; 2018 Feb; 21(1):37-46. PubMed ID: 28993956
[TBL] [Abstract][Full Text] [Related]
9. A peptide inhibitor of synuclein-γ reduces neovascularization of human endometriotic lesions.
Edwards AK; Ramesh S; Singh V; Tayade C
Mol Hum Reprod; 2014 Oct; 20(10):1002-8. PubMed ID: 25024138
[TBL] [Abstract][Full Text] [Related]
10. Calligonum comosum (Escanbil) extract exerts anti-angiogenic, anti-proliferative and anti-inflammatory effects on endometriotic lesions.
Kiani K; Rudzitis-Auth J; Scheuer C; Movahedin M; Sadati Lamardi SN; Malekafzali Ardakani H; Becker V; Moini A; Aflatoonian R; Ostad SN; Menger MD; Laschke MW
J Ethnopharmacol; 2019 Jul; 239():111918. PubMed ID: 31034955
[TBL] [Abstract][Full Text] [Related]
11. Vascular disrupting effects of combretastatin A4 phosphate on murine endometriotic lesions.
Feng D; Menger MD; Laschke MW
Fertil Steril; 2013 Nov; 100(5):1459-67. PubMed ID: 23993929
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase CK2 is a regulator of angiogenesis in endometriotic lesions.
Feng D; Welker S; Körbel C; Rudzitis-Auth J; Menger MD; Montenarh M; Laschke MW
Angiogenesis; 2012 Jun; 15(2):243-52. PubMed ID: 22354315
[TBL] [Abstract][Full Text] [Related]
13. Indole-3-Carbinol Inhibits the Growth of Endometriotic Lesions by Suppression of Microvascular Network Formation.
Rudzitis-Auth J; Becker M; Scheuer C; Menger MD; Laschke MW
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432626
[TBL] [Abstract][Full Text] [Related]
14. Genistein does not affect vascularization and blood perfusion of endometriotic lesions and ovarian follicles in dorsal skinfold chambers of Syrian golden hamsters.
Laschke MW; Schwender C; Vollmar B; Menger MD
Reprod Sci; 2010 Jun; 17(6):568-77. PubMed ID: 20332165
[TBL] [Abstract][Full Text] [Related]
15. Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions.
Laschke MW; Elitzsch A; Vollmar B; Vajkoczy P; Menger MD
Hum Reprod; 2006 Jan; 21(1):262-8. PubMed ID: 16172144
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation.
Laschke MW; Elitzsch A; Scheuer C; Holstein JH; Vollmar B; Menger MD
Br J Pharmacol; 2006 Sep; 149(2):137-44. PubMed ID: 16894343
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine 1 Phosphate (S1P) Increased IL-6 Expression and Cell Growth in Endometriotic Cells.
Yoshino O; Yamada-Nomoto K; Kano K; Ono Y; Kobayashi M; Ito M; Yoneda S; Nakashima A; Shima T; Onda T; Osuga Y; Aoki J; Saito S
Reprod Sci; 2019 Nov; 26(11):1460-1467. PubMed ID: 30782093
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Cyclooxygenase-2 Suppresses the Recruitment of Endothelial Progenitor Cells in the Microvasculature of Endometriotic Lesions.
Rudzitis-Auth J; Nickels RM; Menger MD; Laschke MW
Am J Pathol; 2018 Feb; 188(2):450-460. PubMed ID: 29154961
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.
Nagahashi M; Ramachandran S; Kim EY; Allegood JC; Rashid OM; Yamada A; Zhao R; Milstien S; Zhou H; Spiegel S; Takabe K
Cancer Res; 2012 Feb; 72(3):726-35. PubMed ID: 22298596
[TBL] [Abstract][Full Text] [Related]
20. The ischemic time window of ectopic endometrial tissue crucially determines its ability to develop into endometriotic lesions.
Rudzitis-Auth J; Huwer SI; Scheuer C; Menger MD; Laschke MW
Sci Rep; 2022 Apr; 12(1):5625. PubMed ID: 35379836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
